- Report
- April 2025
- 276 Pages
Global
From €5166EUR$5,450USD£4,316GBP
- Report
- May 2024
- 182 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- March 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Report
- March 2022
- 120 Pages
Global
From €2370EUR$2,500USD£1,980GBP
- Report
- April 2023
- 110 Pages
Global
From €4502EUR$4,750USD£3,761GBP
Infectious Enteritis is a type of Gastrointestinal Drug used to treat a variety of gastrointestinal infections. It is a broad-spectrum antibiotic that is effective against a wide range of bacteria, including Salmonella, Shigella, and Campylobacter. It is also used to treat traveler's diarrhea, which is caused by bacteria or parasites. Infectious Enteritis is available in both oral and injectable forms. It is usually taken as a single dose or in multiple doses over a period of time.
The Infectious Enteritis Drug market is a rapidly growing segment of the Gastrointestinal Drugs market. It is driven by the increasing prevalence of gastrointestinal infections, as well as the growing demand for effective treatments. The market is expected to continue to grow in the coming years, as new treatments are developed and more people become aware of the need for effective treatments.
Some of the major companies in the Infectious Enteritis Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more